Agilent Technologies Inc vs Rigetti Computing Inc — how do they compare? Agilent Technologies Inc trades at $148.05 (market cap $42.22B), while Rigetti Computing Inc trades at $18.38 (market cap $6.04B). The key difference: Agilent Technologies Inc is far larger — about 7× Rigetti Computing Inc's market cap, and Agilent Technologies Inc pays a 0.68% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals.
| A | RGTI | |
|---|---|---|
Market Cap | $42.22B | $6.04B |
Sector | Health | Technology |
52-Week High | $157.20 | $56.34 |
52-Week Low | $110.24 | $12.90 |
Enterprise Value | $43.77B | $5.65B |
Dividend Yield | 0.68% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.77, up 0.03% on the day, near its consensus price target of $154.90. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings beat expectations in Q1 2026, and the company maintains robust profitability with a 19.55% net income margin. Key developments include FDA and EU regulatory approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its biopharma portfolio.
Outlook remains positive with analyst consensus at Buy (77.5%) and a projected 4.1% upside to the price target. Risks include elevated valuation multiples (P/E 30.02) and dependence on healthcare sector growth. Earnings on August 26, 2026, will be critical for validating continued momentum amid competitive and macroeconomic pressures.
Rigetti Computing (RGTI) trades at $18.24, up 3.31% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth of 185% to $5.1 million, beating estimates, but posted a net loss of $0.05 per share, missing expectations. Despite negative profitability metrics, analyst consensus is strongly bullish with 85.7% buy ratings. Recent news highlights government backing and quantum computing advancements, though high spending and losses persist.
The outlook for RGTI hinges on its ability to scale revenue and achieve profitability amid intense competition. Investment opportunity lies in its strategic position in quantum computing and potential government funding, but risks include sustained cash burn, execution challenges, and market volatility. The stock remains speculative, suitable for risk-tolerant investors betting on long-term quantum adoption.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →